Related Experiment Video

Updated: May 21, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Lin28 regulates HER2 and promotes malignancy through multiple mechanisms

Chen Feng1, Veronique Neumeister, Wei Ma

  • 1Department of Obstetrics, Gynecology and Reproductive Sciences, Yale Stem Cell Center, Yale University School of Medicine, New Haven, CT, USA.

Cell Cycle (Georgetown, Tex.)
|June 21, 2012
PubMed

Insights

The RNA binding protein Lin28 stimulates the expression of HER2, a key protein in breast cancer. Lin28 overexpression predicts poor prognosis in breast cancer patients, highlighting its role in cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Lin28 and Lin28B are RNA binding proteins linked to advanced cancers.
  • They are known to inhibit the tumor suppressor let-7 miRNA, contributing to cancer.
  • HER2 is a critical receptor tyrosine kinase in breast cancer cell proliferation and survival.

Purpose of the Study:

  • To investigate the role of Lin28 in regulating HER2 expression.
  • To explore the mechanisms by which Lin28 promotes cancer cell growth.
  • To determine the clinical significance of Lin28 expression in breast cancer prognosis.

Main Methods:

  • Posttranscriptional regulation analysis of HER2 mRNA.
  • Enforced expression studies in cancer cells.
  • Correlation analysis of Lin28 expression with clinical outcomes in primary breast tumors.

Main Results:

  • Lin28 was identified as a regulator of HER2 mRNA.
  • Lin28 stimulates HER2 expression at the posttranscriptional level.
  • Enforced Lin28 expression promoted cancer cell growth through multiple pathways.
  • Lin28 overexpression is a strong predictor of poor prognosis in breast cancer.

Conclusions:

  • Lin28 regulates HER2 expression posttranscriptionally, adding to known gene amplification mechanisms.
  • Lin28 overexpression is linked to poor clinical outcomes in breast cancer.
  • Lin28's pleiotropic gene regulation suggests a common theme of targeting multiple pathways in cancer.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...